| Dr Aaron Daniel Heller, DO | |
|
2305 Genoa Business Park Dr Ste 200, Brighton, MI 48114 | |
| (810) 494-6840 | |
| (810) 494-6841 |
| Full Name | Dr Aaron Daniel Heller |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 2305 Genoa Business Park Dr Ste 200, Brighton, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245689850 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 5101022204 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Joseph Mercy Livingston Hospital | Howell, MI | Hospital |
| St Joseph Mercy Hospital | Ann arbor, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iha Health Services Corporation | 2466351440 | 911 |
News Archive
While much attention has focused on the link between violent video game playing and aggression among youths, a new study finds significantly increased signs of depression among preteens with high daily exposure to violent video games.
CareFusion, a BD company, today announced the U.S. Food and Drug Administration has cleared two 510(k)s for its spine augmentation devices.
Strativa Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the new drug application (NDA) for Zuplenz® (ondansetron) oral soluble film for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic chemotherapy, radiotherapy and surgery.
Using gene therapy to produce a mutant human protein with unusually high blood-clotting power, scientists have successfully treated dogs with the bleeding disorder hemophilia, without triggering an unwanted immune response.
› Verified 5 days ago
| Entity Name | Iha Health Services Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457408965 PECOS PAC ID: 2466351440 Enrollment ID: O20040108000355 |
News Archive
While much attention has focused on the link between violent video game playing and aggression among youths, a new study finds significantly increased signs of depression among preteens with high daily exposure to violent video games.
CareFusion, a BD company, today announced the U.S. Food and Drug Administration has cleared two 510(k)s for its spine augmentation devices.
Strativa Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the new drug application (NDA) for Zuplenz® (ondansetron) oral soluble film for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic chemotherapy, radiotherapy and surgery.
Using gene therapy to produce a mutant human protein with unusually high blood-clotting power, scientists have successfully treated dogs with the bleeding disorder hemophilia, without triggering an unwanted immune response.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aaron Daniel Heller, DO 24 Frank Lloyd Wright Dr Lbby J2000, Ann Arbor, MI 48105-9484 Ph: (734) 747-6766 | Dr Aaron Daniel Heller, DO 2305 Genoa Business Park Dr Ste 200, Brighton, MI 48114 Ph: (810) 494-6840 |
News Archive
While much attention has focused on the link between violent video game playing and aggression among youths, a new study finds significantly increased signs of depression among preteens with high daily exposure to violent video games.
CareFusion, a BD company, today announced the U.S. Food and Drug Administration has cleared two 510(k)s for its spine augmentation devices.
Strativa Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the new drug application (NDA) for Zuplenz® (ondansetron) oral soluble film for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic chemotherapy, radiotherapy and surgery.
Using gene therapy to produce a mutant human protein with unusually high blood-clotting power, scientists have successfully treated dogs with the bleeding disorder hemophilia, without triggering an unwanted immune response.
› Verified 5 days ago
Dr. Robert Michael Camilletti, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2305 Genoa Business Park Dr Ste 200, Brighton, MI 48114 Phone: 810-494-6840 Fax: 810-494-6841 | |
Kimberly Eden Berke, Family Medicine Medicare: Medicare Enrolled Practice Location: 7575 Grand River Rd Ste 210, Brighton, MI 48114 Phone: 810-844-7950 | |
Dr. Rebecca Pawlik, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2305 Genoa Business Park Dr, Suite 200, Brighton, MI 48114 Phone: 810-494-6840 Fax: 810-494-6841 | |
Mr. Jonathan Aaron Koziel, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12851 Grand River Rd, Brighton, MI 48116 Phone: 810-225-2506 Fax: 810-220-5509 | |
Paula Berlin, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 205 W Grand River Ave Ste 200, Brighton, MI 48116 Phone: 810-225-7773 Fax: 810-225-7774 | |
Dr. Stacie Michelle Griffin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 524 Byron Rd., Brighton, MI 48114 Phone: 810-494-6840 Fax: 810-494-6841 | |
James Patrick Gallagher Ii, DO Family Medicine Medicare: Medicare Enrolled Practice Location: Iha Primary Care Genoa, 2305 Genoa Business Park Drive, Brighton, MI 48114 Phone: 810-494-6840 Fax: 810-494-6841 |